Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
for
Treatment-Resistant Depression
Location: Toronto
Sponsor: Centre for Addiction and Mental Health
Sex: All
Age: 18 - 70
Code: NCT07211438
Phase2, Recruiting
Active & Responsive
Characterizing Synaptic Density in Treatment Resistant Depression
for
Treatment Resistant Depression,
Location: Toronto
Sponsor: Unity Health Toronto
Sex: All
Age: 25 - 65
Code: NCT03537794
Recruiting
Active & Responsive
PCS in Severe Treatment Resistant Depression
for
Treatment Resistant Depression
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 22 - 70
Code: NCT04124341
Recruiting
Active & Responsive
Psilocybin rTMS for Treatment Resistant Depression
for
Treatment Resistant Depression, MDD, Major Depressive Disorder,
Location: Austin TX
Sponsor: University of Texas at Austin
Sex: All
Age: 22 - 65
Code: NCT06132178
Phase2, Recruiting
Active & Responsive
Feasibility Trial of Exercise as a Priming Strategy for rTMS Treatment in Difficult-to-Treat Depression
for
Major Depressive Disorder (MDD),
Location: Ottawa
Sponsor: The Royal Ottawa Mental Health Centre
Sex: All
Age: 18 - 70+
Code: NCT06773949
Recruiting
Interested in new treatment resistant depression trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)
for
Treatment Resistant Depression
Location: Toronto
Sponsor: Centre for Addiction and Mental Health
Sex: All
Age: 18 - 65
Code: NCT06512220
Phase2, Recruiting
Active & Responsive
Mindfulness Engaged Neurostimulation for Depression (MEND II)
for
Depression, Treatment Resistant Depression,
Location: San Diego CA
Sponsor: University of California, San Diego
Sex: All
Age: 18 - 65
Code: NCT07512284
Phase2, Recruiting
Active & Responsive
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for
Treatment Resistant Depression
Location: Boston MA, Nashua NH, New York NY, Woodbury NY,
Sponsor: LivaNova
Sex: All
Age: 18+
Code: NCT03887715
Recruiting
Active & Responsive
Intravenous Ketamine for Treatment-Resistant Depression
Location: Boston MA, New York NY, New Brunswick NJ,
Sponsor: Abbott Medical Devices
Sex: All
Age: 22 - 70
Code: NCT06423430
Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
for
Treatment Resistant Depression
Location: Watertown MA, Springfield MA, Eatontown NJ, New York NY,
Sponsor: atai Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06524830
Phase2, Recruiting
Active & ResponsiveNew
One-Day cTBS Over the Precuneus
for
Depressive Disorder, Treatment-Resistant,
Location: Belmont MA
Sponsor: Mclean Hospital
Sex: All
Age: 18+
Code: NCT07758010
Recruiting
Active & Responsive
The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder
for
Depression, Treatment Resistant Depression
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18 - 65
Code: NCT04805879
Phase2, Phase3, Recruiting
Active & Responsive
DBS for TRD With the Medtronic Percept PC
for
Major Depressive Disorder, Treatment Resistant Depression
Location: New York NY
Sponsor: Helen Mayberg, MD
Sex: All
Age: 25 - 70
Code: NCT05773755
Recruiting
Active & Responsive
Lumateperone for Late-Life Depression
for
Treatment Resistant Depression (TRD),
Location: St Louis MO
Sponsor: Eric Lenze
Sex: All
Age: 60+
Code: NCT07623135
Phase3, Recruiting
Active & Responsive
rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression
for
Depression, Treatment Resistant
Location: Indianapolis IN
Sponsor: Indiana University
Sex: All
Age: 18 - 70
Code: NCT06511544
Recruiting
Active & Responsive
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
for
Borderline Personality Disorder (BPD),
Location: Toronto
Sponsor: Joshua Rosenblat
Sex: All
Age: 18 - 70
Code: NCT07569198
Phase2, Recruiting
Active & Responsive
E-field Guided iTBS for Treatment Resistant Depression
for
Major Depressive Disorder
Location: Toronto
Sponsor: Centre for Addiction and Mental Health
Sex: All
Age: 18 - 65
Code: NCT05583747
Recruiting
Active & ResponsiveNew
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
for
Major Depression
Location: Philadelphia PA, Birmingham AL, Tuscaloosa AL,